Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib

Shoumariyeh K, von Bubnoff N

Blood and Lymphatic Cancer: Targets and Therapy 2014, 4:81-89

Published Date: 18 September 2014